Amylyx Pharmaceuticals to Present at the 7th Annual Evercore ISI HealthCONx Conference
27 Novembre 2024 - 3:00PM
Business Wire
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the
“Company”) today announced that management will participate in the
7th Annual Evercore ISI HealthCONx Conference. The conference is
being conducted in-person in Coral Gables, Florida, and the
fireside chat will take place on Wednesday, December 4, 2024, at
11:15 a.m. ET.
A live webcast of the fireside chat can be accessed under
“Events and Presentations” in the Investor section of the Company’s
website, https://investors.amylyx.com/news-events/events, and will
be available for replay for 90 days following the event.
About Amylyx Pharmaceuticals
Amylyx is committed to the discovery and development of new
treatment options for communities with high unmet needs, including
people living with serious and fatal neurodegenerative diseases and
endocrine conditions. Since its founding, Amylyx has been guided by
science to address unanswered questions, keeping communities at the
heart and center of all decisions. Amylyx is headquartered in
Cambridge, Massachusetts. For more information, visit amylyx.com
and follow us on LinkedIn and X. For investors, please visit
investors.amylyx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241127937550/en/
Media Amylyx Media Team +1 (857) 799-7274
amylyxmediateam@amylyx.com
Investors Lindsey Allen Amylyx Pharmaceuticals, Inc. +1 (857)
320-6244 Investors@amylyx.com
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
